Using Twitter as a Regulatory Intelligence Tool: 300 Accounts Worth Following
Alexander Gaffney (Regulatory Focus / RAPS)
Clinical Trials Facts and Figures
Center for Information and Study on Clinical Research Participation CISCRP
Do Clinical Trials Work?
Clifton Leaf (New York Times)
Does A Decline In Phase 1 Starts Signal A Future Pharma Productivity Gap?
John Lamattina (Forbes)
NIH confirms it is shelving India drug trials in wake of new regs
John Carroll (FierceBiotech)
You Just Don't Understand (R&D)
David Shaywitz (Forbes)
Comment on, and links to other key discussion around GSK's idea to give bonuses to scientistis involved in the development of successful drugs.
DEALTALK-Biotech takeover interest more fad than fashion
Deena Beasley (Reuters)
Alexander Gaffney (Regulatory Focus / RAPS)
Clinical Trials Facts and Figures
Center for Information and Study on Clinical Research Participation CISCRP
Do Clinical Trials Work?
Clifton Leaf (New York Times)
Does A Decline In Phase 1 Starts Signal A Future Pharma Productivity Gap?
John Lamattina (Forbes)
NIH confirms it is shelving India drug trials in wake of new regs
John Carroll (FierceBiotech)
You Just Don't Understand (R&D)
David Shaywitz (Forbes)
Comment on, and links to other key discussion around GSK's idea to give bonuses to scientistis involved in the development of successful drugs.
DEALTALK-Biotech takeover interest more fad than fashion
Deena Beasley (Reuters)
RSS Feed
